![](/images/graphics-bg.png)
Efficacy and Safety of the Triple Therapy Containing Ilaprazole, Levofloxacin, and Amoxicillin as First-Line Treatment in Helicobacter pylori Infections
المؤلفون المشاركون
Lee, Dong-Soo
Ahn, Hyo Jun
Kim, Dong Pil
Chu, Myeong Su
Yun, Hyeon Jeong
Kim, Seok-Hwan
Lee, Seung Woo
المصدر
Gastroenterology Research and Practice
العدد
المجلد 2017، العدد 2017 (31 ديسمبر/كانون الأول 2017)، ص ص. 1-6، 6ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2017-04-30
دولة النشر
مصر
عدد الصفحات
6
التخصصات الرئيسية
الملخص EN
Background and Aims.
To establish the efficacy and safety of ilaprazole, levofloxacin, and amoxicillin as a first-line eradication treatment for Helicobacter pylori.
Methods.
Patients with gastric ulcer, duodenal ulcer, or gastritis, as detected by esophagogastroduodenoscopy with confirmed H.
pylori infection between September 2014 and November 2015, were enrolled in the study.
All participants received ilaprazole (10 mg bid), levofloxacin (500 mg bid), and amoxicillin (1000 mg bid) for 10 days.
H.
pylori eradication was confirmed by a 13C-urea breath test at 6–8 weeks after the end of treatment.
Results.
Of 84 patients included in the analysis, the eradication rate was 88.8% in the per protocol group (n=80).
Demographic factors such as age, gender, body mass index (BMI), alcohol, smoking, hypertension, diabetes mellitus, and peptic ulcer did not affect the eradication rate.
However, multivariate analysis showed that overweight patients and patients with cerebrovascular accident (CVA) had a significantly lower eradication rate than patients with normal BMI and without CVA.
Laboratory test results did not change significantly after treatment.
A total of six (7.5%) patients developed eight adverse reactions.
Conclusions.
A 10-day triple therapy containing ilaprazole, levofloxacin, and amoxicillin is a safe alternative first-line eradication treatment for H.
pylori.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Ahn, Hyo Jun& Kim, Dong Pil& Chu, Myeong Su& Yun, Hyeon Jeong& Kim, Seok-Hwan& Lee, Seung Woo…[et al.]. 2017. Efficacy and Safety of the Triple Therapy Containing Ilaprazole, Levofloxacin, and Amoxicillin as First-Line Treatment in Helicobacter pylori Infections. Gastroenterology Research and Practice،Vol. 2017, no. 2017, pp.1-6.
https://search.emarefa.net/detail/BIM-1156165
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Ahn, Hyo Jun…[et al.]. Efficacy and Safety of the Triple Therapy Containing Ilaprazole, Levofloxacin, and Amoxicillin as First-Line Treatment in Helicobacter pylori Infections. Gastroenterology Research and Practice No. 2017 (2017), pp.1-6.
https://search.emarefa.net/detail/BIM-1156165
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Ahn, Hyo Jun& Kim, Dong Pil& Chu, Myeong Su& Yun, Hyeon Jeong& Kim, Seok-Hwan& Lee, Seung Woo…[et al.]. Efficacy and Safety of the Triple Therapy Containing Ilaprazole, Levofloxacin, and Amoxicillin as First-Line Treatment in Helicobacter pylori Infections. Gastroenterology Research and Practice. 2017. Vol. 2017, no. 2017, pp.1-6.
https://search.emarefa.net/detail/BIM-1156165
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-1156165
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
![](/images/ebook-kashef.png)
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر
![](/images/kashef-image.png)